報價延遲最少15分鐘:2025/08/25 16:58 EDT
盤後時段
|
||||
|
3.46 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.46
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.36/-1.22
|
|
企業價值
276.34M
|
| 資產負債 |
|
每股賬面淨值
3.58
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
0
|
|
每股收益
0.13
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/08/25 16:58 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotopeLead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties. |
